# Invesco DB Oil Fund: financial statements, quarterly

DBO · NYSE · CIK 1383058 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dbo.md) · [Financials](/companies/dbo/financials.md) · [Filings](/companies/dbo/filings.md) · [Insiders](/companies/dbo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dbo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [2.9](/filings/0000950170-24-122590.md) | [3.2 d](/filings/0001193125-26-083549.md) | [2.8](/filings/0000950170-25-067173.md) | [2.8](/filings/0000950170-25-105197.md) | [2.4](/filings/0001193125-25-270333.md) | [2.2 d](/filings/0001193125-26-083549.md) | [1.7](/filings/0001193125-26-209732.md) | [1.6](/filings/0001193125-26-338716.md) | [2.0](/filings/0001193125-25-270333.md) | [1.7 d](/filings/0001193125-26-083549.md) | [1.6](/filings/0001193125-26-209732.md) | [2.3](/filings/0001193125-26-338716.md) |
| Interest expense | $m | [0.0](/filings/0000950170-24-122590.md) | [0.0 d](/filings/0000950170-24-019057.md) | [0.0](/filings/0000950170-24-054959.md) | [0.0](/filings/0000950170-24-092105.md) | [0.0](/filings/0000950170-24-122590.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [58.2](/filings/0000950170-24-122590.md) | [(54.0) d](/filings/0001193125-26-083549.md) | [26.8](/filings/0000950170-25-067173.md) | [4.0](/filings/0000950170-25-105197.md) | [(26.8)](/filings/0001193125-25-270333.md) | [15.5 d](/filings/0001193125-26-083549.md) | [2.7](/filings/0001193125-26-209732.md) | [(13.8)](/filings/0001193125-26-338716.md) | [4.0](/filings/0001193125-25-270333.md) | [(12.3) d](/filings/0001193125-26-083549.md) | [134](/filings/0001193125-26-209732.md) | [(19.4)](/filings/0001193125-26-338716.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [1.0](/filings/0001193125-26-083549.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [278](/filings/0000950170-23-060455.md) | [245](/filings/0000950170-25-027272.md) | [252](/filings/0000950170-24-054959.md) | [236](/filings/0000950170-24-092105.md) | [250](/filings/0000950170-24-122590.md) | [212](/filings/0001193125-26-083549.md) | [202](/filings/0000950170-25-067173.md) | [229](/filings/0000950170-25-105197.md) | [220](/filings/0001193125-25-270333.md) | [205](/filings/0001193125-26-338716.md) | [388](/filings/0001193125-26-209732.md) | [216](/filings/0001193125-26-338716.md) |
| Total liabilities | $m | [9.7](/filings/0000950170-23-060455.md) | [1.2](/filings/0000950170-25-027272.md) | [0.1](/filings/0000950170-24-054959.md) | [1.0](/filings/0000950170-24-092105.md) | [39.3](/filings/0000950170-24-122590.md) | [0.1](/filings/0001193125-26-083549.md) | [0.1](/filings/0000950170-25-067173.md) | [0.4](/filings/0000950170-25-105197.md) | [0.1](/filings/0001193125-25-270333.md) | [0.7](/filings/0001193125-26-338716.md) | [23.0](/filings/0001193125-26-209732.md) | [5.3](/filings/0001193125-26-338716.md) |
| Shareholders' equity | $m | [269](/filings/0000950170-24-122590.md) | [244](/filings/0001193125-26-083549.md) | [252](/filings/0000950170-25-105197.md) | [235](/filings/0001193125-25-270333.md) | [211](/filings/0001193125-25-270333.md) | [212](/filings/0001193125-26-338716.md) | [202](/filings/0001193125-26-338716.md) | [228](/filings/0001193125-26-338716.md) | [219](/filings/0001193125-25-270333.md) | [204](/filings/0001193125-26-338716.md) | [365](/filings/0001193125-26-338716.md) | [211](/filings/0001193125-26-338716.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [32.3 d](/filings/0000950170-24-122590.md) | [(22.8) d](/filings/0001193125-26-083549.md) | [19.8](/filings/0000950170-25-067173.md) | [20.8 d](/filings/0000950170-25-105197.md) | [(2.5) d](/filings/0001193125-25-270333.md) | [15.0 d](/filings/0001193125-26-083549.md) | [11.5](/filings/0001193125-26-209732.md) | [(38.4) d](/filings/0001193125-26-338716.md) | [11.5 d](/filings/0001193125-25-270333.md) | [2.2 d](/filings/0001193125-26-083549.md) | [(26.8)](/filings/0001193125-26-209732.md) | [133 d](/filings/0001193125-26-338716.md) |
| Dividends paid | $m | not reported | not reported | [0.2](/filings/0000950170-25-067173.md) | [0.0 d](/filings/0000950170-25-105197.md) | [0.0 d](/filings/0001193125-25-270333.md) | [10.0 d](/filings/0001193125-26-083549.md) | [0.0](/filings/0000950170-25-067173.md) | [0.0 d](/filings/0000950170-25-105197.md) | [0.0 d](/filings/0001193125-25-270333.md) | [7.1 d](/filings/0001193125-26-083549.md) | not reported | not reported |
| Share repurchases | $m | [75.1 d](/filings/0000950170-24-122590.md) | [62.6 d](/filings/0001193125-26-083549.md) | [39.6](/filings/0000950170-25-067173.md) | [30.2 d](/filings/0000950170-25-105197.md) | [16.3 d](/filings/0001193125-25-270333.md) | [23.8 d](/filings/0001193125-26-083549.md) | [29.9](/filings/0001193125-26-209732.md) | [26.0 d](/filings/0001193125-26-338716.md) | [38.5 d](/filings/0001193125-25-270333.md) | [29.9 d](/filings/0001193125-26-083549.md) | [80.0](/filings/0001193125-26-209732.md) | [136 d](/filings/0001193125-26-338716.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 12,050,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338716.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.